Related Experiment Video
Updated: Jan 6, 2026

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
Stable angina in young women
Carolyn M Webb1, Peter Collins1
1National Heart & Lung Institute, Imperial College London, and Royal Brompton Hospital, Sydney Street, London SW3 6NP, UK.
Insights
Ischaemic heart disease (IHD) is rising in young women, with angina as a key symptom. This review explores IHD risk factors, pathophysiological mechanisms, and treatment options specific to women.
Area of Science:
- Cardiology and Women's Health
Background:
- Ischaemic heart disease (IHD) is a leading cause of global cardiovascular death.
- IHD prevalence and mortality are increasing in younger women, particularly in high-income countries.
- Angina, a primary symptom of IHD, is linked to increased cardiovascular event risk and future premature IHD in young women.
Purpose of the Study:
- To review stable angina in young women.
- To explore pathophysiological mechanisms, including hormonal influences.
- To present IHD risk factors and potential treatments in women, highlighting research gaps.
Main Methods:
- Literature review of stable angina in young women.
- Analysis of pathophysiological mechanisms and risk factors.
- Discussion of treatment options and evidence gaps.
Main Results:
- Angina presentation in young women may have unique characteristics, including cyclical patterns potentially influenced by ovarian hormones.
- Traditional IHD risk factors exist, but female hormones and reproductive history significantly impact lifelong IHD risk.
- Specific pathophysiological mechanisms in young women require further investigation.
Conclusions:
- Stable angina in young women warrants specific consideration due to unique pathophysiological mechanisms and hormonal influences.
- Understanding sex differences in IHD risk factors and the impact of female hormones is crucial for effective prevention and treatment.
- Further research is needed to address evidence gaps in managing IHD in young women.
Abstract:
Ischaemic heart disease (IHD) is the primary cause of cardiovascular death worldwide. Worryingly, the prevalence of IHD is increasing in younger women, with a 3% increase between 1990 and 2019. Although global IHD death rates have decreased in younger women overall, IHD mortality in younger women is increasing in certain high-income countries. Angina is the primary presenting symptom of suspected IHD and coronary artery disease. The presence of angina in patients with stable coronary artery disease is associated with an increased risk of major cardiovascular events compared with those without angina. Angina in young women is linked to future premature IHD events. There are particular features to consider in younger women presenting with stable angina-anginal symptom characterization may align with older women, but angina may occur cyclically in younger women and a similar pattern may be evident on diagnostic testing. Pathophysiologic mechanisms for angina in some young women may involve effects of ovarian hormones on vascular beds of the cardiovascular system. Traditional IHD risk factors are common to women and men; however, there are certain sex differences in their relevance to IHD risk, as well as influences that female hormones and reproduction have over a life course that affect IHD risk. In this review, we will explore stable angina in young women, consider possible pathophysiological mechanisms involved in their symptom presentation, and present risk factors associated with IHD in women. In addition, potential treatment options will be discussed and attention will be drawn to gaps in the evidence, proposing areas where more research is necessary.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
07:59Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
Published on: April 4, 2022
Related Concept Videos
Angina III: Clinical Manifestations and Assessment
Angina I: Introduction
Angina II: Classification
Angina V: Nursing Management
Angina IV: Management
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....